daily news Investing Sage shares surge 15% after FDA OKs expedited depression drug development By amazon Saturday, June 16, 2018 Comment Edit Sage Therapeutics says the FDA has cleared it to expedite development of its drug to treat depression. from Investing https://ift.tt/2JIKE1V Related PostsItaly’s political turmoil could mark the end of the EU, roiling global marketsUBS: Sell Tesla shares because carmaker will need to raise capital in the fourth quarter or earlierAnalyst: Owning Washington Post makes Bezos target of Trump, and that's not great for Amazon investors'Caution is going to be the word here,' says former super bull Jeremy Siegel
0 Response to "Sage shares surge 15% after FDA OKs expedited depression drug development"
Post a Comment